Scopolamine (3 mg/kg IP) given before an acquisition trial, reduced the retention of a one-trial passive avoidance "step through" response in mice. A single administration of cholinergic agonists such as oxotremorine, BM-5, or arecoline, antagonized this amnesic effect of scopolamine. A significant
β¦ LIBER β¦
Effects of acute doses of oxiracetam in the scopolamine model of human amnesia
β Scribed by Laura Preda; Margherita Alberoni; Sergio Bressi; Carlo Cattaneo; Jacopo Parini; Nicola Canal; Massimo Franceschi
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 649 KB
- Volume
- 110
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Effects of nootropic drugs in a scopolam
β
R. Verloes; A.-M. Scotto; J. Gobert; E. WΓΌlfert
π
Article
π
1988
π
Springer
π
English
β 455 KB
Acute dose-effects of scopolamine on fal
β
Miriam Z. Mintzer; Roland R. Griffiths
π
Article
π
2000
π
Springer
π
English
β 65 KB
Oxiracetam antagonizes the disruptive ef
β
M. Magnani; O. Pozzi; R. Biagetti; S. Banfi; L. Dorigotti
π
Article
π
1992
π
Springer
π
English
β 484 KB
Effect of aceclidine on scopolamine- and
β
M. D. Mashkovskii; V. A. Parshin; R. B. Parimbetova
π
Article
π
1997
π
Springer US
π
English
β 285 KB
The ameliorating effects of the cognitiv
β
Ming-Tsuen Hsieh; Wen-Huang Peng; Chi-Rei Wu; Wen-Hsin Wang
π
Article
π
2000
π
John Wiley and Sons
π
English
β 39 KB
π 1 views
Effects of acute doses of zimelidine on
β
Renato B. Reyes; Shirley Y. Hill; David J. Kupfer
π
Article
π
1983
π
Springer
π
English
β 368 KB
Sleep EEG (7 h) were obtained from 11 rats given 5, 10, and 20 mg/kg zimelidine, and a control dose of saline. Zimelidine significantly suppressed REM sleep, lengthened REM latency, and reduced total sleep time (TST) in a dosedependent manner. Sleep latency was not affected except at the highest dos